These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 8719480)

  • 1. Estrogen and prevention of transplant atherosclerosis.
    Foegh ML; Zhao Y; Lou H; Katz NM; Ramwell PW
    J Heart Lung Transplant; 1995; 14(6 Pt 2):S170-2. PubMed ID: 8719480
    [No Abstract]   [Full Text] [Related]  

  • 2. The pathogenesis of graft vascular disease: implications of vascular remodeling.
    Gibbons GH
    J Heart Lung Transplant; 1995; 14(6 Pt 2):S149-58. PubMed ID: 8719477
    [No Abstract]   [Full Text] [Related]  

  • 3. Vascular effects of cyclosporin A and acute rejection in canine heart transplantation.
    Bouchard D; Despatis MA; Buluran J; Cartier R
    Ann Thorac Surg; 1997 Nov; 64(5):1325-30. PubMed ID: 9386698
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Time course of coronary endothelial dysfunction in acute untreated rejection after heterotopic heart transplantation.
    Perrault LP; Bidouard JP; Janiak P; Villeneuve N; Bruneval P; Vilaine JP; Vanhoutte PM
    J Heart Lung Transplant; 1997 Jun; 16(6):643-57. PubMed ID: 9229295
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hemostasis, fibrinolysis, and natural anticoagulation in transplant vascular sclerosis.
    Faulk WP; Labarrere CA; Nelson DR; Pitts D
    J Heart Lung Transplant; 1995; 14(6 Pt 2):S158-64. PubMed ID: 8719478
    [No Abstract]   [Full Text] [Related]  

  • 6. Acute rejection, cytomegalovirus infection and endothelial dysfunction early after heart transplantation.
    Sabaté M; Manito N; Cequier A; Roca J; Mauri J; Jara F; Gomez-Hospital JA; Ruiz-Majoral A; Sala J; Alcaide P
    Transplant Proc; 1995 Aug; 27(4):2346-8. PubMed ID: 7652837
    [No Abstract]   [Full Text] [Related]  

  • 7. [Coronary endothelial dysfunction and graft atheromatosis following heart transplantation].
    Vassalli G
    Schweiz Med Wochenschr; 1995 Oct; 125(41):1923-30. PubMed ID: 7481650
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Receptor-specific effects of acute rejection after heart transplantation on endothelium-dependent coronary relaxation in dogs.
    Bouchard D; Cartier R; Despatis MA; Carrier M; Leung TK
    J Heart Lung Transplant; 1996 Apr; 15(4):404-8. PubMed ID: 8732600
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hormone replacement therapy and cardiovascular disease.
    McPherson R; Tardif JC; Jolly E
    Can J Cardiol; 2001 Nov; 17 Suppl D():32D-37D. PubMed ID: 11726994
    [No Abstract]   [Full Text] [Related]  

  • 10. L-arginine prevents heart transplant arteriosclerosis by modulating the vascular cell proliferative response to insulin-like growth factor-I and interleukin-6.
    Lou H; Kodama T; Wang YN; Katz N; Ramwell P; Foegh ML
    J Heart Lung Transplant; 1996 Dec; 15(12):1248-57. PubMed ID: 8981210
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The new conundrum: do estrogens have any cardiovascular benefits?
    Clarkson TB
    Int J Fertil Womens Med; 2002; 47(2):61-8. PubMed ID: 11991432
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The prognostic significance of intimal proliferation in cardiac allograft vasculopathy: a paradigm shift.
    Mehra MR; Ventura HO; Stapleton DD; Smart FW
    J Heart Lung Transplant; 1995; 14(6 Pt 2):S207-11. PubMed ID: 8719487
    [No Abstract]   [Full Text] [Related]  

  • 13. Early proliferation of medial smooth muscle cells in coronary arteries of rabbit cardiac allografts during immunosuppression with cyclosporine A.
    Tanaka H; Swanson SJ; Sukhova G; Schoen FJ; Libby P
    Transplant Proc; 1995 Jun; 27(3):2062-5. PubMed ID: 7792886
    [No Abstract]   [Full Text] [Related]  

  • 14. Cyclosporine treatment preserves coronary resistance artery function in rat cardiac allografts.
    Moien-Afshari F; Choy JC; McManus BM; Laher I
    J Heart Lung Transplant; 2004 Feb; 23(2):193-203. PubMed ID: 14761767
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Action of natural estrogens on the vessel wall: molecular mechanisms and clinical implications].
    Lüscher TF; Barton M; Wight E; Espinosa E; Yang Z
    Schweiz Med Wochenschr; 1996 Oct; 126(41):1748-55. PubMed ID: 8966507
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Allograft vasculopathy versus atherosclerosis.
    Rahmani M; Cruz RP; Granville DJ; McManus BM
    Circ Res; 2006 Oct; 99(8):801-15. PubMed ID: 17038650
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sex hormone replacement therapy and modulation of vascular function in cardiovascular disease.
    Koledova VV; Khalil RA
    Expert Rev Cardiovasc Ther; 2007 Jul; 5(4):777-89. PubMed ID: 17605655
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transplant vascular disease: role of lipids and proteoglycans.
    Rahmani M; McDonald PC; Wong BW; McManus BM
    Can J Cardiol; 2004 Aug; 20 Suppl B():58B-65B. PubMed ID: 15309207
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Status of the endothelium-derived hyperpolarizing factor pathway in coronary arteries after heterotopic heart transplantation.
    Perrault LP; Aubin MC; Malo O; Thollon C; Villeneuve N; Vilaine JP; Vanhoutte PM
    J Heart Lung Transplant; 2007 Jan; 26(1):48-55. PubMed ID: 17234517
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Vascular protection with estrogen. In-vitro and in-vivo effects--mechanisms and clinical implication].
    Barton M; Wright E; Dai-Do D; Yang Z; Espinosa E; Arnet U; Lüscher TF
    Praxis (Bern 1994); 1997 Jan; 86(5):129-37. PubMed ID: 9064730
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.